These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Association of the CFH Y402H Polymorphism with the 1-Year Response of Exudative AMD to Intravitreal Anti-VEGF Treatment in the Brazilian Population. Medina FMC, Motta AALD, Takahashi WY, Carricondo PC, Motta MMDS, Melo MB, Vasconcellos JPC. Ophthalmic Res; 2019; 61(3):168-173. PubMed ID: 28641277 [Abstract] [Full Text] [Related]
6. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment. Goverdhan SV, Hannan S, Newsom RB, Luff AJ, Griffiths H, Lotery AJ. Eye (Lond); 2008 Jun; 22(6):849-54. PubMed ID: 17464302 [Abstract] [Full Text] [Related]
8. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration. Bonyadi M, Foruzandeh Z, Mohammadian T, Fotouhi N, Soheilian M, Jabbarpoor Bonyadi MH, Javadzadeh A, Moein H, Yaseri M. Acta Ophthalmol; 2016 Dec; 94(8):e779-e785. PubMed ID: 27316788 [Abstract] [Full Text] [Related]
10. Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: a meta-analysis. Jabbarpoor Bonyadi MH, Yaseri M, Nikkhah H, Bonyadi M, Nazari R, Soheilian M. Int Ophthalmol; 2019 Apr; 39(4):949-956. PubMed ID: 29423786 [Abstract] [Full Text] [Related]
11. [Association between Y402H, E318D and R102G polymorphisms of complement proteins genes and the response to intravitreal anti-VEGF treatment in patients with neovascular age-related macular degeneration]. Kubicka-Trząska A, Karska-Basta I, Kobylarz J, Dziedzina S, Sanak M, Romanowska-Dixon B. Klin Oczna; 2016 Apr; 118(2):114-21. PubMed ID: 29912491 [Abstract] [Full Text] [Related]
13. Association of the Complement Factor H Y402H Polymorphism and Response to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration: An Updated Meta-Analysis. Roshanshad A, Moosavi SA, Arevalo JF. Ophthalmic Res; 2024 Apr; 67(1):358-386. PubMed ID: 38754401 [Abstract] [Full Text] [Related]
14. Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice. Landowski M, Kelly U, Klingeborn M, Groelle M, Ding JD, Grigsby D, Bowes Rickman C. Proc Natl Acad Sci U S A; 2019 Feb 26; 116(9):3703-3711. PubMed ID: 30808757 [Abstract] [Full Text] [Related]
18. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP, Boekhoorn SS, Vingerling JR, Hofman A, Oostra BA, Uitterlinden AG, Stijnen T, van Duijn CM, de Jong PT. JAMA; 2006 Jul 19; 296(3):301-9. PubMed ID: 16849663 [Abstract] [Full Text] [Related]
20. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Wegscheider BJ, Weger M, Renner W, Steinbrugger I, März W, Mossböck G, Temmel W, El-Shabrawi Y, Schmut O, Jahrbacher R, Haas A. Ophthalmology; 2007 Apr 19; 114(4):738-42. PubMed ID: 17398321 [Abstract] [Full Text] [Related] Page: [Next] [New Search]